{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:35:51Z","timestamp":1793968551571,"version":"4.8.0"},"reference-count":91,"publisher":"Informa UK Limited","issue":"3","funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/COE\/34\/SP15097\/2015"],"award-info":[{"award-number":["BT\/COE\/34\/SP15097\/2015"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2023,2,11]]},"DOI":"10.1080\/14656566.2022.2161366","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T15:04:01Z","timestamp":1671635041000},"page":"389-399","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["A review of therapeutic failures in late-stage clinical trials"],"prefix":"10.1080","volume":"24","author":[{"given":"Ritu","family":"Jain","sequence":"first","affiliation":[{"name":"Department of Chemical Engineering, Indian Institute of Technology Delhi, 110016, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0083-9896","authenticated-orcid":false,"given":"Janakiraman","family":"Subramanian","sequence":"additional","affiliation":[{"name":"Division of Oncology, Saint Luke\u2019s Cancer Institute\/University of Missouri, 64111, Kansas City, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5913-4244","authenticated-orcid":false,"given":"Anurag S.","family":"Rathore","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, Indian Institute of Technology Delhi, 110016, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,12,26]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1517\/17460441.2010.521496"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2009.24.1.1"},{"key":"#cr-split#-cit0003.1","unstructured":"U.S. Food & Drug Administration. Step 3: clinical research [Internet]. [updated 2018 Apr"},{"key":"#cr-split#-cit0003.2","unstructured":"cited 2022 Jan 15]. Available from: https:\/\/www.fda.gov\/patients\/drug-development-process\/step-3-clinical-research"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2016.01.012"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.25.2.420"},{"key":"cit0006","unstructured":"Modernizing drug discovery, development & approval [Internet]. PhRMA. [updated 2016 Mar; cited 2022 Jan 25]. Available from: http:\/\/www.phrma.org\/report\/policy-solutions-modernizing-drug-discovery-development-and-approval"},{"key":"cit0007","unstructured":"Clinical trials market size, share & trends analysis report by phase (Phase I, Phase II, Phase III, Phase IV), by study design (interventional, observational, expanded access), by indication, by region, and segment forecasts, 2021 \u2013 2028 [Internet]. [updated 2021 Jun; cited 2022 Jan 25]. Available from: https:\/\/www.grandviewresearch.com\/industry-analysis\/global-clinical-trials-market#:~:text=How%20big%20is%20the%20clinical,USD%2047.0%20billion%20in%202021"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxx069"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-018-0204-y"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.6008"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3284"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1680"},{"key":"cit0013","volume-title":"Experimental and clinical neurotoxicology","author":"Spencer PS","year":"2000"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313369"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.5b00407"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.2000.1399"},{"key":"cit0017","unstructured":"American Heart Association. What your cholesterol levels mean [Internet]. [updated 2016; cited 2022 Feb 18]. Available from: http:\/\/www.heart.org\/HEARTORG\/Conditions\/Cholesterol\/AboutCholesterol\/What-Your-Cholesterol-Levels-Mean_UCM_305562_Article.jsp#"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070635"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.9.5033"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114132"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.20.9.2106"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)74263-X"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1038\/364073a0"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.4.1105"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118255"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.52.36912"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000118278.21719.17"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61088-5"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071359"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706628"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008-1512"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32399-1"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt269"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.151261398"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3181cb577a"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312889"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705971"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90160-0"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-016-0189-7"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2377-07.2008"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c67808"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4163"},{"key":"cit0043","unstructured":"Roche provides update on Phase III study of dalcetrapib [Internet]. Roche. [updated 2012 May;cited 2022 Feb 23]. Available from: https:\/\/www.roche.com\/media\/releases\/med-cor-2012-05-07.htm"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00460.x"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000015857.31889.7B"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.12.064"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.02.061"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp601"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61383-4"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs019"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.114.000663"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.116.001405"},{"key":"cit0053","unstructured":"DalCor Pharmaceuticals. Effect of dalcetrapib vs placebo on CV risk in a genetically defined population with a recent ACS (dal-GenE) [ClinicalTrials.gov identifier NCT02525939] [Internet]. US National Institutes of Health, ClinicalTrials.gov. [updated 2015 Aug; cited 2022 Feb 25]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02525939"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003252244"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.05.006"},{"key":"#cr-split#-cit0056.1","unstructured":"US Food and Drug Administration draft guidance for industry: enrichment strategies for clinical trials to support approval of human drugs and biological Products [Internet]. US FDA. [updated 2012"},{"key":"#cr-split#-cit0056.2","unstructured":"cited 2022 Feb 18]. Available from: http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm332181.pdf"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903044982"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21623"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.8.1031"},{"key":"cit0060","unstructured":"Eli Lilly and Company. Effect of LY450139 on the long term progression of Alzheimer\u2019s disease. [ClinicalTrials.gov identifier NCT00594568] [Internet]. US National Institutes of Health, ClinicalTrials.gov. [updated 2014 Sept; cited 2022 Mar 4]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00594568"},{"key":"cit0061","unstructured":"Eli Lilly and Company. Effects of LY450139, on the progression of Alzheimer\u2019s disease as compared with placebo (IDENTITY-2) [ClinicalTrials.gov identifier NCT00762411] [Internet]. US National Institutes of Health, ClinicalTrials.gov. [updated 2014 Sept; cited 2022 Mar 4]. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00762411"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1210951"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00072"},{"key":"cit0064","unstructured":"The Semagacestat Molecule [Internet]. The interactive Library. [cited 2022 Mar 4]. Available from: https:\/\/www.edinformatics.com\/interactive_molecules\/info\/Semagacestat.htm"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.176"},{"key":"cit0066","unstructured":"Encenicline misses endpoints in two phase 3 schizophrenia trials [Internet]. ALZFORUM. [updated 2016 Mar; cited 2022 Mar 4]. Available from: https:\/\/www.alzforum.org\/news\/research-news\/encenicline-misses-endpoints-two-phase-3-schizophrenia-trials"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.20373"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706444"},{"key":"cit0069","unstructured":"Merck says will not seek approval of cholesterol treatment [Internet]. Healthcare & pharma. Reuters. [updated 2017 Oct; cited 2022 Mar 4]. Available from: https:\/\/www.reuters.com\/article\/us-merck-cholesterol-idUSKBN1CG2W1"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.447"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.19"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2018.08.001"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-016-1402-5"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2017.09.043"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1177\/1756285612461679"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0201-z"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13230"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.33"},{"key":"cit0079","unstructured":"Biohaven provides update on phase 2\/3 trial and Alzheimer\u2019s disease program [Internet]. News release. [updated 2021 Jan;cited 2022 Mar 5]. Available from: https:\/\/www.prnewswire.com\/news-releases\/biohaven-provides-update-on-phase-23-trial-and-alzheimers-disease-program-301210022.html"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113685"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-016-0509-x"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159328"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2015.04.020"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.03.048"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-016-1876-7"},{"key":"cit0086","unstructured":"Trends, charts, and maps [Internet]. NIH US National Library of Medicine. ClinicalTrials.gov. [updated 2021 Mar; cited 2022 Mar 5]. Available from: https:\/\/clinicaltrials.gov\/ct2\/resources\/trends"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2758"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-012-0118-9"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.7b00025"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2022.2161366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T19:01:32Z","timestamp":1676919692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2022.2161366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,2,11]]}},"alternative-id":["10.1080\/14656566.2022.2161366"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2022.2161366","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-08-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}